Cite
HARVARD Citation
Ivers, L. et al. (n.d.). 239 Tyrosine kinase inhibitors (TKIs) enhance response to HER2 targeted antibodies. European journal of cancer. pp. S40-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ivers, L. et al. (n.d.). 239 Tyrosine kinase inhibitors (TKIs) enhance response to HER2 targeted antibodies. European journal of cancer. pp. S40-. [Online].